LRMR
Price
$3.04
Change
-$0.04 (-1.30%)
Updated
Jun 27, 01:08 PM (EDT)
Capitalization
197.21M
41 days until earnings call
UBX
Price
$0.78
Change
-$0.01 (-1.27%)
Updated
Jun 27, 04:02 PM (EDT)
Capitalization
13.51M
Interact to see
Advertisement

LRMR vs UBX

Header iconLRMR vs UBX Comparison
Open Charts LRMR vs UBXBanner chart's image
Larimar Therapeutics
Price$3.04
Change-$0.04 (-1.30%)
Volume$892
Capitalization197.21M
Unity Biotechnology
Price$0.78
Change-$0.01 (-1.27%)
Volume$261
Capitalization13.51M
LRMR vs UBX Comparison Chart in %
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. UBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Buy and UBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (LRMR: $3.08 vs. UBX: $0.79)
Brand notoriety: LRMR and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 114% vs. UBX: 19%
Market capitalization -- LRMR: $197.21M vs. UBX: $13.51M
LRMR [@Biotechnology] is valued at $197.21M. UBX’s [@Biotechnology] market capitalization is $13.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, LRMR is a better buy in the long-term than UBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 5 TA indicator(s) are bullish while UBX’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 5 bullish, 5 bearish.
  • UBX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both LRMR and UBX are a good buy in the short-term.

Price Growth

LRMR (@Biotechnology) experienced а +12.41% price change this week, while UBX (@Biotechnology) price change was -0.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.93%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.52%.

Reported Earning Dates

LRMR is expected to report earnings on Aug 07, 2025.

UBX is expected to report earnings on Apr 22, 2025.

Industries' Descriptions

@Biotechnology (+9.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($197M) has a higher market cap than UBX($13.5M). UBX (-19.603) and LRMR (-20.413) have similar YTD gains . UBX has higher annual earnings (EBITDA): -24.46M vs. LRMR (-105.02M). LRMR has more cash in the bank: 158M vs. UBX (16.9M). LRMR has less debt than UBX: LRMR (4.87M) vs UBX (18.7M). LRMR (0) and UBX (0) have equivalent revenues.
LRMRUBXLRMR / UBX
Capitalization197M13.5M1,459%
EBITDA-105.02M-24.46M429%
Gain YTD-20.413-19.603104%
P/E RatioN/AN/A-
Revenue00-
Total Cash158M16.9M935%
Total Debt4.87M18.7M26%
FUNDAMENTALS RATINGS
LRMR vs UBX: Fundamental Ratings
LRMR
UBX
OUTLOOK RATING
1..100
6519
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3865
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (22) in the null industry is in the same range as UBX (52) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as UBX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's SMR Rating (100) in the null industry is in the same range as UBX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's Price Growth Rating (38) in the null industry is in the same range as UBX (65) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as UBX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRUBX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QDEL28.700.59
+2.10%
QuidelOrtho Corp
CW482.786.28
+1.32%
Curtiss-Wright Corp
KARO47.300.55
+1.18%
Karooooo Ltd
ACRS1.56-0.07
-4.29%
Aclaris Therapeutics
NXTT2.20-0.33
-13.04%
Next Technology Holding

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-5.23%
ERAS - LRMR
53%
Loosely correlated
-8.70%
IMNM - LRMR
50%
Loosely correlated
+1.27%
ATXS - LRMR
50%
Loosely correlated
-3.72%
ACLX - LRMR
49%
Loosely correlated
+1.16%
ALEC - LRMR
48%
Loosely correlated
+0.67%
More